학술논문
A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults
Document Type
Article
Author
Source
In: Journal of Travel Medicine . (Journal of Travel Medicine, 1 March 2024, 31(2))
Subject
Language
English
ISSN
17088305
11951982
11951982